
### [NCIT:C28292](http://purl.obolibrary.org/obo/NCIT_C28292)
**Label:** Squamous Cell Carcinoma In Situ of the Nipple

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 54.16%
- [NCIT:C28079](http://purl.obolibrary.org/obo/NCIT_C28079) (Grade 3) 51.85%
- [NCIT:C14158](http://purl.obolibrary.org/obo/NCIT_C14158) (High Grade) 51.85%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C14161](http://purl.obolibrary.org/obo/NCIT_C14161) (Low Grade))) 51.85%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39092](http://purl.obolibrary.org/obo/NCIT_C39092) (Growth Hormone Signaling Pathway))) 37.21%
- [NCIT:C18000](http://purl.obolibrary.org/obo/NCIT_C18000) (Histologic Grade) and (not ([NCIT:C39091](http://purl.obolibrary.org/obo/NCIT_C39091) (Corticosteroid Cardioprotection Pathway))) 37.21%


